PTAB Issues Guidance On SAS Trial Impact

The U.S. Copyright Office recently released a report on the human authorship requirement for materials to qualify for copyright protection.

Universal Music Group's lawsuit against DistroKid raises a critical question about AI disclosure in consumer markets: when does the use of artificial intelligence become material information that must be disclosed to consumers? The case centers on allegations that DistroKid distributed mass-generated AI music while creating the impression it was created by legitimate human artists, potentially violating existing consumer protection laws even without specific AI disclosure requirements.

The USPTO has released its latest economic impact report on IP-intensive industries, announced a new community engagement office in North Carolina, and issued several administrative updates including relief for Japanese applicants affected by a severe earthquake. The Patent Trial and Appeal Board has also designated new precedential and informative decisions addressing obviousness-type double patenting and Markush groupings.

Bristol-Myers Squibb and Ono Pharmaceutical have filed a patent infringement lawsuit against Amgen over its proposed nivolumab biosimilar ABP 206, asserting seven patents related to OPDIVO. The complaint follows earlier inter partes review challenges and patent dance negotiations that narrowed the dispute to specific claims covering the antibody sequence, cancer treatment methods, and dosing regimens.

There was a significant ruling in the Doe v. Github case involving training of AI code generator models on open source. The United States Court of Appeals for The Ninth Circuit affirmed the district court ruling dismissing part of an action brought under the Digital Millennium Copyright Act (“DMCA”) by programmers against GitHub, Inc., and other defendants. The issues centered on whether defendants removed copyright management information (CMI) from content used to train the AI code generator models.

In recent video game news, gaming giant Nintendo filed and settled a lawsuit against the developers of the popular Nintendo Switch emulator, Yuzu.

AI-powered call transcription tools like Otter.ai are facing class action lawsuits under Illinois' Biometric Information Privacy Act (BIPA) for allegedly collecting voiceprints without proper consent. A federal court recently allowed claims to proceed, signaling potential legal risks for companies that provide or utilize these increasingly common meeting recording services.

The U.S. government has filed a Statement of Interest of the United States of America under 28 U.S.C. § 517 in the Southern District of New York multidistrict litigation over OpenAI’s use of copyrighted works to train large language models. The filing appears to be the federal government’s first direct intervention in the wave of artificial intelligence (AI) training copyright cases, and it advises the court to treat model training (separate from use of AI to generate outputs) on copyrighted text standing alone as a highly transformative fair use under current law.

If it seems to you that the process of obtaining federal trademark registration has become more complicated and time-consuming in recent years, you are not alone.

The U.S. Patent and Trademark Office (USPTO) announced on January 14, 2025, a new Artificial Intelligence (AI) Strategy which provides a vision for how the USPTO can encourage accountable AI innovation.

Today, the Patent Trial & Appeal Bord designated two decisions informative that apply the so-called "Fintiv factors."

As explained earlier this week in a study by my partner Filko Prugo, Orange & Purple Book patents fare no worse at the PTAB than in the courts.

On June 1, 2023, China's Ministry of Science and Technology (the "MOST") issued the long-awaited Implementing Rules on the Administrative Regulations on Human Genetic Resources...

Extradition from Japan is rare, and even more so for Japanese nationals in connection with white collar offenses. But on April 17, 2019,

Learn how Ropes & Gray mobilized resources in response to executive orders restricting travel.

A sentencing hearing is scheduled before U.S. District Court Judge Loretta A. Preska on March 19, 2019.

China will launch further reforms in the pharmaceutical sector as part of the healthcare reform initiatives announced by the State Council in its February 9, 2017 Circular on Several Opinions Concerning Further Reforms of the Policies Governing Drug Production, Circulation and Usage (the "Circular No.13").

What is the current outlook for North American infrastructure? Ropes & Gray attorneys explored this question at the Infrastructure Investor America Forum in New York on November 4–5, drawing...

The UK Treasury confirmed today that it will amend Article 53 of the Regulated Activities Order (covering the regulated activity of "advising on investments") to bring it into line with...

The latest constitutional challenge to the Patent Trial & Appeal Board (PTAB) involves the Appointments Clause.